fluorodeoxyglucose f18 has been researched along with Cutaneous T-Cell Lymphoma in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (46.67) | 29.6817 |
2010's | 7 (46.67) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Kan, Y; Lu, X; Wang, W; Yang, J | 1 |
Imataki, O; Kadowaki, N; Uchida, S; Uemura, M; Yokokura, S | 1 |
Collins, GP; Corcoran, JP; Davies, SJ; Ho, LP; Moore, AJ | 1 |
Cascavilla, A; Legnani, G; Magistrelli, E; Manfredi, R; Sabbatani, S | 1 |
Alavi, A; Fardin, S; Gholami, S; Rook, AH; Samimi, S | 1 |
Fujiwara, H; Matsue, K; Sandoh, E | 1 |
Dai, W; Feng, X; Guan, Y; Hua, F; Zhao, J | 1 |
Berger, F; Pfluger, T; Reiser, MF; Schramm, N | 1 |
Jeong, HJ; Jeong, YJ; Kim, DW; Kim, JS; Kwak, JY; Lim, ST; Sohn, MH; Yim, CY | 1 |
Alavi, A; Fried, RG; Junkins-Hopkins, JM; Rook, AH; Saidman, BH; Schulman, N; Shapiro, M; Vittorio, CC; Yun, M | 1 |
Agress, H; Felig, DM; Sedarat, A; Waintraub, SE | 1 |
Becherer, A; Der-Petrossian, M; Hoffmann, M; Raderer, M; Trautinger, F; Valencak, J | 1 |
Alavi, A; Kumar, R; Xiu, Y; Zhuang, HM | 1 |
Ben-Yehuda, D; Cohen, T; Freund, HR; Klein, M; Krausz, Y; Nissan, A | 1 |
Armitage, JO; Bishu, S; Bishu, SR; Hankins, JH; Holdeman, KH; Olsasky, SM; Paknikar, S; Quigley, JM; Schmitz, J; Stemm, RA | 1 |
15 other study(ies) available for fluorodeoxyglucose f18 and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
Primary Cutaneous Natural Killer/T-Cell Lymphoma: A Posttransplant Lymphoproliferative Disorder Demonstrated by 18F-FDG PET/CT.
Topics: Bone Marrow Transplantation; Fluorodeoxyglucose F18; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Young Adult | 2021 |
Small Primary Cutaneous γδT-Cell Lymphoma Lesions Successfully Treated With Pralatrexate.
Topics: Adult; Aminopterin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Positron-Emission Tomography; Skin Neoplasms; Treatment Outcome | 2019 |
A 72-year-old woman with a persistent cough and abnormal chest X-ray.
Topics: Aged; Antinematodal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
A patient with a 12-year history characterized by four non-AIDS-related malignancies, occurring before and after the disclosure of HIV infection.
Topics: Carcinoma, Papillary; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Iodine Radioisotopes; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Radionuclide Imaging; Syphilis; Thyroid Neoplasms; Thyroidectomy; Viral Load | 2015 |
Global Quantitative Techniques for Positron Emission Tomographic Assessment of Disease Activity in Cutaneous T-Cell Lymphoma and Response to Treatment.
Topics: Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2016 |
(18)F-Fluorodeoxyglucose positron emission tomography in primary cutaneous NK/T cell lymphoma, nasal type.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Nose Neoplasms; Positron-Emission Tomography; Radiography | 2009 |
F-18 FDG PET/CT in granulomatous slack skin.
Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Male; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Subcutaneous panniculitis-like T-cell lymphoma with breast involvement: functional and morphological imaging findings.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Panniculitis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subcutaneous Tissue; Thorax; Tomography, X-Ray Computed; Upper Extremity | 2010 |
Before and after treatment 18F-FDG PET/CT images in a patient with cutaneous T-cell lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Neoplasm Staging; Radiopharmaceuticals; Skin Diseases; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Colonic adenomas detected by F-FDG PET.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Male; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Skin Neoplasms | 2004 |
18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2006 |
18F-fluorodeoxyglucose-avid thyroid incidentalomas in patients with lymphoma.
Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2006 |
F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |